Lobular Carcinoma in Situ
📧 Sign up to get email alerts when something new happens for Lobular Carcinoma in Situ.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial [Phase 2]
Phase 2 trial update evaluating the optimal Tamoxifen dose for breast cancer risk reduction in premenopausal women (RENAISSANCE). The study …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer [Phase 2]
A Phase 2 clinical trial comparing acolbifene versus low-dose tamoxifen for prevention of breast cancer in high-risk premenopausal women; cu…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE) [NA]
MiCHOICE is a clinical trial assessing chemoprevention strategies for women with atypical hyperplasia of the breast and lobular carcinoma in…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer [NA]
The document provides an update on a clinical trial evaluating hypofractionated regional nodal irradiation for women with breast cancer, wit…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women
A Mayo Clinic-backed clinical trial is evaluating the addition of a genetic risk evaluation to standard breast cancer risk assessment specif…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients
Clinical trial update for the LobulCard Trial, which aims to identify novel germline mutations in lobular breast cancer patients; the study …
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion [Phase 2]
This Phase 2 clinical trial evaluates low-dose tamoxifen plus lifestyle changes for breast cancer prevention in individuals with BRCA mutati…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating real-time MRI-guided 3-fraction accelerated partial breast irradiation for early breast cancer is curren…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease
This clinical trial update describes a completed study that collected blood and tumor tissue samples from women with invasive breast cancer,…
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Impact of Dietary Inflammatory Potential on Breast Cancer Risk
This clinical trial is recruiting to evaluate whether the inflammatory potential of a person's diet affects breast cancer risk. The study in…
-
CLINICAL_TRIALS research · 2012-07-16Clinical Trial Update: "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer" [Phase 2]
Phase II clinical trial evaluating PET-guided neoadjuvant chemotherapy and Oncotype-guided hormonal therapy for breast cancer.